Mad Money host Jim Cramer says don't chase stocks, especially when they have moved as much as Sarepta has today. Chris Garabedian, Sarepta Therapeutics president & CEO, weighs in.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT